| Mtasiwa D, Mayombana C, Kilima
P, Tanner M. Validation of reagent sticks in diagnosing
urinary schistosomiasis in an urban setting. East
Afr Med J. 1996 Mar;73(3):198-200. Menendez C,
Kahigwa E, Hirt R, Vounatsou P, Aponte JJ, Font
F, Acosta CJ, Schellenberg DM, Galindo CM, Kimario
J, Urassa H, Brabin B, Smith TA, Kitua AY, Tanner
M, Alonso PL. Randomised placebo-controlled trial
of iron supplementation and malaria chemoprophylaxis
for prevention of severe anaemia and malaria in
Tanzanian infants. Lancet. 1997 Sep 20;350(9081):844-50.
Schellenberg DM, Abdalla S, Mshinda H. Malarial
drug trials. Trans R Soc Trop Med Hyg. 1997 Nov-Dec;91(6):727.
Utzinger J, Mayombana C, Mez K, Tanner M. Evaluation
of chemical and physical-morphological factors
as potential determinants of Biomphalaria pfeifferi
(Krauss, 1848) distribution. Mem Inst Oswaldo
Cruz. 1997 May-Jun;92(3):323-8.
Wang P, Lee CS, Bayoumi R, Djimde A, Doumbo O,
Swedberg G, Dao LD, Mshinda H, Tanner M, Watkins
WM, Sims PF, Hyde JE. Resistance to antifolates
in Plasmodium falciparum monitored by sequence
analysis of dihydropteroate synthetase and dihydrofolate
reductase alleles in a large number of field samples
of diverse origins. Mol Biochem Parasitol. 1997
Nov;89(2):161-77.
Kitua AY, Smith TA, Alonso PL, Urassa H, Masanja
H, Kimario J, Tanner M. The role of low level
Plasmodium falciparum parasitaemia in anaemia
among infants living in an area of intense and
perennial transmission. Trop Med Int Health. 1997
Apr;2(4):325-33.
Beck HP, Felger I, Huber W, Steiger S, Smith
T, Weiss N, Alonso P, Tanner M. Analysis of multiple
Plasmodium falciparum infections in Tanzanian
children during the phase III trial of the malaria
vaccine SPf66. J Infect Dis. 1997 Apr;175(4):921-6.
Bordmann G, Burmeister G, Saladin S, Urassa H,
Mwankyusye S, Weiss N, Tanner M. MRP 8/14 as marker
for Plasmodium falciparum-induced malaria episodes
in individuals in a holoendemic area. Clin Diagn
Lab Immunol. 1997 Jul;4(4):435-9.
|
